Chuck Bradley

Chuck Bradley has a diverse work experience in the biopharmaceutical industry. Chuck currently holds the position of SVP Clinical Development Operations at Kinevant Sciences since 2023. Before joining Kinevant Sciences, they worked at Annexon Biosciences as SVP Global Development Operations from 2021 to 2023. Prior to that, Chuck was associated with FibroGen, Inc., where they served as Vice President of Clinical Development from 2018 to 2021 and as Executive Director of Clinical Operations from 2013 to 2017. Chuck also worked as an Independent Consultant specializing in Clinical Development and Clinical Operations from 2011 to 2013. Before that, they held the role of VP Clinical Development at bipar sciences from 2005 to 2011. Chuck's early career includes roles at Amgen as Sr Assoc Director, Medical/Clinical Affairs/Clinical Operations from 2000 to 2005 and at Guilford Pharmaceuticals as Director of Clinical Operations from 1997 to 2000.

Chuck Bradley attended the University of Delaware, but there is no information available regarding the specific degree, field of study, or duration of their education there.